Search Results1-8 of  8

  • 竹村 佐千哉 ID: 9000018516360

    Articles in CiNii:1

    • 疾患の理解編 (疾患と看護がわかる看護過程 ナーシングプロセス 白血病) (2011)
  • TAKEMURA Sachiya ID: 9000000569647

    Department of Chemotherapy, Kanagawa Cancer Center (2010 from CiNii)

    Articles in CiNii:11

    • CD16^+CD56^-Indolent, NK Cell-lineage Granular Lymphocyte Proliferative Disorder with Autoimmune Hemolytic Anemia (2000)
    • Treatment outcome in elderly patients with aggressive non-Hodgkin's lymphoma (2000)
    • Role of endothelin in gastric microcirculatory changes induced by portal hypertension (2001)
  • TAKEMURA Sachiya ID: 9000258040799

    Department of Hematology, Yokohama City University Medical Center (2000 from CiNii)

    Articles in CiNii:1

    • Treatment outcome in elderly patients with aggressive non-Hodgkin's lymphoma (2000)
  • TAKEMURA Sachiya ID: 9000258042389

    Department of Hematology, Shizuoka Red Cross Hospital (2004 from CiNii)

    Articles in CiNii:1

    • Complex additional chromosomal abnormalities of del(5q), del(7q), and +22 in a patient with acute myelomonocytic leukemia carrying inv(16) (2004)
  • TAKEMURA Sachiya ID: 9000258043076

    Department of Hematology, Shizuoka Red Cross Hospital (2007 from CiNii)

    Articles in CiNii:1

    • Systemic neurolymphomatosis complicated in diffuse large B-cell lymphoma (2007)
  • TAKEMURA Sachiya ID: 9000258044328

    Department of Chemotherapy, Kanagawa Cancer Center (2010 from CiNii)

    Articles in CiNii:1

    • ABVD chemotherapy for Hodgkin lymphoma at a single institute (2010)
  • TAKEMURA Sachiya ID: 9000283537837

    Department of Hematology, Shizuoka Red Cross Hospital (2005 from CiNii)

    Articles in CiNii:1

    • Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-<i>trans</i> retinoic acid (2005)
  • TAKEMURA Sachiya ID: 9000290820622

    Department of Internal Medicine, Yokohama Ekisaikai Hospital (2015 from CiNii)

    Articles in CiNii:1

    • Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy (2015)
Page Top